06 Sep 2021

Dexus Healthcare Property Fund acquires high-quality hospital in Sydney

Dexus Healthcare Property Fund acquires high-quality hospital in Sydney

Dexus Healthcare Property Fund (DHPF) has acquired Arcadia Pittwater Private Hospital (Arcadia Pittwater) and day rehabilitation facility, adding another high-quality asset to its growing portfolio.

Arcadia Pittwater is a 5-level private sub-acute rehabilitation hospital located in Warriewood on the Northern Beaches of Sydney. Completed in 2018, the hospital was purpose built for Arcadia Health Care with 85 beds, consulting suites, physiotherapy space and a hydrotherapy pool.

The property was acquired in an off-market transaction for $50.5 million and is 100% leased to Arcadia Health Care with a weighted average lease expiry of 26.5 years. In addition, there is an opportunity under the current DA for future brownfield expansion.

DHPF Fund Manager, Jemma Maddick, said: “Arcadia Health Care is a well-established healthcare operator, and we are pleased to welcome this new relationship onto the Dexus platform. This acquisition will deliver another quality asset with a stable income stream for DHPF and continues our strategy to grow and diversify the fund through the acquisition of high-quality developments and stabilised healthcare assets.”

Harry Pannu, CEO, Arcadia Health Care, said: “We welcome the acquisition of Arcadia Pittwater by Dexus, with whom we share a vison for the delivery of premium health care assets and best in class clinical outcomes.”

This acquisition grows DHPF funds under management to over $1.3 billion1 across nine assets and follows circa $600 million of healthcare acquisitions in FY21. DHPF achieved a 12-month total return of 18.1% (post fees) to 30 June 2021.

Click here for an image of Arcadia Pittwater.


  1. Includes Dexus ownership interest in DHPF and the on-completion value of assets under development. Includes Spring Hill Medical Centre and Herston Car Park which are expected to settle in the coming months.



Rowena Causley

Head of Listed Investor Relations

Related Articles

See More Investor Articles
Back to top